[히츠] Understanding Hyperlab workflows with the FDA-approved drug Pirtobrutinib in 2023
- 작성자히츠
- 작성일자
- 조회424
At the Drug Discovery Conference (DDC) 2024 and American Association of Cancer Research (AACR) 2024, held in April 2024, HITS unveiled Hyper Lab to the world. In this post, we will introduce a research scenario to demonstrate the use cases of Hyper Lab.
